Cart
sales@molnova.com
Terflavoxate
CAS No. 86433-40-1
Terflavoxate( —— )
Catalog No. M36117 CAS No. 86433-40-1
Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 199 | In Stock |
|
| 5MG | 174 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 762 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTerflavoxate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTerflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
-
DescriptionTerflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMicrotubule Associated
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number86433-40-1
-
Formula Weight419.51
-
Molecular FormulaC26H29NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(OC(CN1CCCCC1)(C)C)(=O)C2=C3C(C(=O)C(C)=C(O3)C4=CC=CC=C4)=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rehmapicrogenin
Rehmapicrogenin regulates the Nrf2/ARE signaling pathway. Nrf2/ARE signaling pathway is the most important pathway of oxidative stress.
-
Human Papillomavirus...
Human Papillomavirus E7 protein (49 - 57)
-
Thymine
Thymine is found in the nucleic acid DNA. In RNA thymine is replaced with uracil in most cases. In DNA, thymine binds to adenine via two hydrogen bonds to assist in stabilizing the nucleic acid structures.
